Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genasense + RICE in Relapsed B-Cell NHL
NCT00086944Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2004
- Primary completion
- Jul 2006
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 2 trial of oblimersen in B-cell non-Hodgkin lymphoma, sponsored by National Cancer Institute. Started May 2004; status: completed.
02
Drugs
oblimersen
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00086944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086944.